Selfapys Online-Kurs bei Bulimia Nervosa

DiGA App for Bulimia · permanently listed

Selfapys Online-Kurs bei Bulimia Nervosa App at a Glance

🇩🇪 Legally binding original Rechtsverbindliches Original · BfArM

Der Selfapy Online-Kurs ist eine digitale Anwendung für Betroffene einer Bulimia Nervosa. Der Kurs vermittelt Methoden und Techniken basierend auf der kognitiven Verhaltenstherapie und unterstützt bei der Durchführung sowie der Dokumentation der Übungen, mit dem Ziel, die Symptomatik des Anwendenden zu verbessern.-Dabei liefert Selfapy hilfreiche Informationen zum Thema Essstörungen. Die Anwendung stellt sicher, dass Patientinnen und Patienten nur Zugang zu validierten, unkritischen und sicheren Inhalten erhalten, die anhand von Videos, Audios, Grafiken und Texten in ansprechender Gestaltung aufbereitet sind. Die Anwendung ist einfach zu nutzen und bietet den Patientinnen und Patienten damit ein modernes Hilfsmittel zur selbstständigen Durchführung von etablierten Selbsthilfe-Therapiemethoden in unkritischen Phasen.-Die digitale Gesundheitsanwendung (DiGA) ist im Versorgungspfad für die Überbrückung der Wartezeit auf einen Therapieplatz oder als alleinstehende Therapie einzuordnen. Diese Einordnung basiert auf dem dargelegten Evaluationskonzept, in dem die Interventionsgruppe der systematischen Datenanalyse neben der DiGA keine weitere explizite Versorgung erhielt. Probandinnen und Probanden in aktiver psychotherapeutischer oder pharmakologischer Behandlung bezüglich ihrer Essstörungssymptomatik wurden von der Datenanalyse ausgeschlossen. Diese Einordnung spiegelt die Situation vieler Nutzenden von Selfapys Online-Kursen wider.

🇬🇧 English translation automatically translated

The Selfapy Online Course is a digital application for individuals affected by bulimia nervosa. The course teaches methods and techniques based on cognitive behavioral therapy and supports the implementation as well as the documentation of exercises, with the aim of improving the user's symptoms. In doing so, Selfapy provides helpful information on the topic of eating disorders. The application ensures that patients only have access to validated, non-critical, and safe content, which is presented in an appealing design using videos, audios, graphics, and texts. The application is easy to use and thus offers patients a modern tool for the independent implementation of established self-help therapy methods during non-critical phases. The digital health application (DiGA) is to be classified within the care pathway as bridging the waiting time for a therapy place or as a stand-alone therapy. This classification is based on the presented evaluation concept, in which the intervention group of the systematic data analysis did not receive any further explicit care in addition to the DiGA. Subjects in active psychotherapeutic or pharmacological treatment regarding their eating disorder symptoms were excluded from the data analysis. This classification reflects the situation of many users of Selfapy's online courses.

Automatically translated for informational purposes · Source: BfArM· Updated 10/19/2026

Category

Mental Health

Indicated for

Bulimia

Manufacturer

medigital GmbH, Deutschland

Listed Since

2023-01-05 - permanently listed

Help and Support for the Selfapys Online-Kurs bei Bulimia Nervosa App

Questions about the app, signing in or the activation code are answered by the manufacturer, medigital GmbH. We only run this directory and have no access to your app or your account.

Go to medigital GmbH support

What are the experiences with the Selfapys Online-Kurs bei Bulimia Nervosa app?

Apple App Store

3.1 · 96 ratings
Download on the App Store

Google Play Store

2.7 · 152 ratings
Get it on Google Play

Ratings from the Apple App Store or Google Play Store as of 11/7/2026. We do not verify whether they come from people who have actually used the app.

These ratings apply to the whole app in the store, which is also used for 3 other DiGAs.

Details

Indicated for ICD-10

  • F50.2Bulimia nervosa
  • F50.3Atypical bulimia nervosa

Source: ICD-10 2019 (WHO)

Contraindications

  • F10.2Mental and behavioural disorders due to use of alcohol: Dependence syndrome
  • F10.3Mental and behavioural disorders due to use of alcohol: Withdrawal state
  • F11.2Mental and behavioural disorders due to use of opioids: Dependence syndrome
  • F11.3Mental and behavioural disorders due to use of opioids: Withdrawal state
  • F12.2Mental and behavioural disorders due to use of cannabinoids: Dependence syndrome
  • F12.3Mental and behavioural disorders due to use of cannabinoids: Withdrawal state
  • F13.2Mental and behavioural disorders due to use of sedatives or hypnotics: Dependence syndrome
  • F13.3Mental and behavioural disorders due to use of sedatives or hypnotics: Withdrawal state
25 more
  • F14.2Mental and behavioural disorders due to use of cocaine: Dependence syndrome
  • F14.3Mental and behavioural disorders due to use of cocaine: Withdrawal state
  • F15.2Mental and behavioural disorders due to use of other stimulants, including caffeine: Dependence syndrome
  • F15.3Mental and behavioural disorders due to use of other stimulants, including caffeine: Withdrawal state
  • F16.2Mental and behavioural disorders due to use of hallucinogens: Dependence syndrome
  • F16.3Mental and behavioural disorders due to use of hallucinogens: Withdrawal state
  • F17.2Mental and behavioural disorders due to use of tobacco: Dependence syndrome
  • F17.3Mental and behavioural disorders due to use of tobacco: Withdrawal state
  • F18.2Mental and behavioural disorders due to use of volatile solvents: Dependence syndrome
  • F18.3Mental and behavioural disorders due to use of volatile solvents: Withdrawal state
  • F19.2Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances: Dependence syndrome
  • F19.3Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances: Withdrawal state
  • F20Schizophrenia
  • F21Schizotypal disorder
  • F22Persistent delusional disorders
  • F23Acute and transient psychotic disorders
  • F24Induced delusional disorder
  • F25Schizoaffective disorders
  • F28Other nonorganic psychotic disorders
  • F29Unspecified nonorganic psychosis
  • F31Bipolar affective disorder
  • F32.2Severe depressive episode without psychotic symptoms
  • F32.3Severe depressive episode with psychotic symptoms
  • F33.2Recurrent depressive disorder, current episode severe without psychotic symptoms
  • F33.3Recurrent depressive disorder, current episode severe with psychotic symptoms

Source: ICD-10 2019 (WHO)

Prescription Period

90 days

PZN

18468376

How much does the Selfapys Online-Kurs bei Bulimia Nervosa app cost?

Free with statutory health insurance

Health insurance cost: 232.00 EUR for 90 days

Medical Device Risk Class

Risk class I under MDR

Last changed (BfArM)

10/19/2026

Age Group

Adults between 18 and 65 years

Additional Devices

none

Languages

German

Where can I find the Selfapys Online-Kurs bei Bulimia Nervosa app?

FAQ

Find all the answers to your questions about the Selfapys Online-Kurs bei Bulimia Nervosa app here.